In one of the most notable announcements in today’s D2C news India, sleep science and recovery startup DUSQ has raised ₹24 crore in a seed funding round led by Fireside Ventures, marking a significant moment for Direct-to-consumer India and the broader D2C ecosystem India. The round also saw participation from Antler India, Climber Capital, Startup Sherpas, Vaishav Investments, Avnish Anand (Founder, CaratLane), and Shivam Puri — positioning DUSQ among the VC-backed D2C brands shaping the future of India’s health-tech innovation.
Formerly known as InnerGize, DUSQ operates at the intersection of neuroscience and hardware design, building infrastructure for human recovery rather than “just another tracker.” In a landscape dominated by wearables that merely monitor sleep, DUSQ is creating a new category in sleep technology — aligning with the rise of D2C wellness startups, premium D2C brands India, and science-led innovation in the D2C business India landscape.
This latest development stands out in D2C funding news and among the top D2C startup funding this week, reinforcing strong investor confidence in India’s ability to build globally competitive med-tech brands. As D2C funding rounds continue to accelerate across categories — from D2C food and beverage brands to D2C beauty and skincare India, D2C personal care brands, and D2C electronics and gadgets — DUSQ signals how the next wave of latest D2C startups is becoming deeply science-driven.
Founded in 2023 by Siddhant Bhargava, Shalmali Kadu, and Mitansh Khurana, DUSQ has built its platform on over 50 million physiological data points. Over the past year, the company has conducted structured trials in its proprietary sleep lab, testing autonomic recovery pathways under controlled conditions. Early results suggest the system can support sustained recovery cycles and maintain uninterrupted sleep — moving beyond passive tracking toward active improvement. This shift reflects evolving D2C consumer behavior India, where users increasingly demand outcome-driven products rather than vanity metrics.
The ₹24 crore raised will be deployed to expand sleep regulation platforms by strengthening neuroscience and hardware teams, advancing intellectual property development, upgrading in-house sleep labs, and preparing for a U.S. launch. These D2C expansion plans highlight how D2C brands scaling in 2025 are thinking global from day one. In an environment where investors are tracking D2C startup valuation, D2C revenue growth, and potential D2C IPO news, DUSQ’s early traction places it firmly within India’s evolving D2C industry news narrative.
Co-founder Dr. Siddhant Bhargava emphasized, “We’re building infrastructure for human recovery, not another tracker. This funding allows India-built deep-science sleep tech to enter global markets.” Fireside Ventures echoed the optimism, stating that DUSQ combines scientific depth, differentiation, and a launch-ready product capable of defining the global sleep solutions category.
For the D2C market trends 2025, this milestone reinforces that Direct-to-consumer startup IPO tracker conversations may soon include health-tech infrastructure brands, not just consumer goods. As conversations around India’s D2C market news and insights evolve, DUSQ stands out as an example of how fastest-growing D2C brands can merge deep science with a differentiated D2C business model India — strengthening India’s position in the global innovation map.
